Key result
The less frequent GG genotype of the SCN5A rs1805124 polymorphism was associated with a 7.39-fold increased risk of familial dilated cardiomyopathy compared with the AA genotype.
Why the study?
Does the c.1673A>G polymorphism in the SCN5A gene increase the risk of dilated cardiomyopathy in a European-Caucasian population?
Case-Control (n=436)
Single-blind
Yes
Does the c.1673A>G polymorphism in the SCN5A gene increase the risk of dilated cardiomyopathy in a European-Caucasian population?
The GG genotype of the rs1805124 polymorphism in the SCN5A gene is significantly associated with an increased risk of familial dilated cardiomyopathy, suggesting a genetic predisposition role.
May inform SCN5A genotyping in familial DCM families; leaves open prospective validation before practice change.
AIMS: SCN5A is a disease-causing gene associated with familial dilated cardiomyopathy (FDC). We examined the possible association between a common polymorphism in the SCN5A gene (c.1673A>G-p.H558R; rs1805124) and the risk of dilated cardiomyopathy (DCM) occurrence. METHODS: We genotyped 185 DCM cases (familial DCM, idiopathic DCM and postischemic DCM) and 251 controls for the p.H558R polymorphism in the SCN5A gene, to test the association of the molecular epidemiology of the individuals with the presence/absence of various types of DCM. RESULTS: Our results showed that the rs1805124 polymorphism was significantly associated with DCM, and the association was more significant in patients with FDC; furthermore, in these individuals, the less frequent GG genotype was associated with a 7.39-fold increased risk of disease [95% confidence interval (95% CI) = 2.88-18.96; P < 0.0001] compared with the AA genotype. Moreover, logistic regression analysis showed that GG carriers had a higher risk of DCM than AA + AG carriers (odds ratio = 5.45, 95% CI = 2.23-13.35; P < 0.001). No association was observed between the rs1805124 and DCM risk in postischemic DCM patients. CONCLUSION: Our study demonstrates an association between familial DCM and the rs1805124 polymorphism in the SCN5A gene, which may unravel additional genetic predisposition to the development of a multifactorial disease as DCM.
No takes yet. Share an insight, caveat, or question.
Mazzaccara et al. (2018) conducted a case-control in Dilated cardiomyopathy (n=436). SCN5A rs1805124 (c.1673A>G) polymorphism (GG genotype) vs. AA genotype was evaluated on Risk of familial dilated cardiomyopathy (FDC) occurrence (OR 7.39, 95% CI 2.88-18.96, p=<0.0001). The less frequent GG genotype of the SCN5A rs1805124 polymorphism was associated with a 7.39-fold increased risk of familial dilated cardiomyopathy compared with the AA genotype.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: